Your session is about to expire
← Back to Search
Self-Testing for COVID-19 (C-STRAND Trial)
N/A
Waitlist Available
Led By Robert Gross, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, up to one year
Awards & highlights
C-STRAND Trial Summary
This trial will help to assess whether self-testing can increase test uptake in underserved populations and reduce health disparities related to COVID-19.
Eligible Conditions
- Coronavirus
C-STRAND Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, up to one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, up to one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Network contact test uptake
Secondary outcome measures
Network contact test uptake, end of study
Number of contacts tested
Number of contacts tested at 8 weeks
+4 moreC-STRAND Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Self-Test kit distributionExperimental Treatment1 Intervention
Participants in the self-test arm receive multiple COVID-19 self-test kits to distribute to others in their social networks.
Group II: Test referral distributionActive Control1 Intervention
Participants in the test referral arm receive multiple COVID-19 test referral cards and text messages to distribute to others in their social networks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
COVID-19 self-test
2021
N/A
~810
Find a Location
Who is running the clinical trial?
Public Health Management CorporationOTHER
16 Previous Clinical Trials
4,543 Total Patients Enrolled
University of PennsylvaniaLead Sponsor
2,009 Previous Clinical Trials
42,893,862 Total Patients Enrolled
Robert Gross, MDPrincipal Investigator - University of Pennsylvania
Elliot Gross A Prof Corp, Southern California Hospital at Culver City
University Of Pennsylvania School Of Medicine (Medical School)
Vet Affairs Medical Ctr-W La (Residency)
3 Previous Clinical Trials
258 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You had COVID-19 within the last 90 days.
Research Study Groups:
This trial has the following groups:- Group 1: Test referral distribution
- Group 2: Self-Test kit distribution
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current size of enrollment in this medical trial?
"Yes, according to clinicaltrials.gov records this trial is actively searching for participants and has been updated recently on May 16th 2022. When it was initially posted back in 2021 there were ambitions of recruiting 1048 patients from 1 site."
Answered by AI
Is enrollment in this research project still accessible to patients?
"Per the information posted on clinicaltrials.gov, this investigation is still seeking suitable participants. Launched on May 5th 2021 and recently modified on May 16th 2022, it is a current medical trial."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger